The Solomon Center for Health Law and Policy at Yale Law School—in collaboration with Smilow Cancer Hospital and Yale Cancer Center—will host a major interdisciplinary conference addressing topics at the cutting edge of cancer policy.

Titled “The Policy, Politics and Law of Cancer,” the conference will be held in New Haven on February 8-9th, 2018.

Conference Objectives

This event brings together leading figures in the worlds of cancer care, research, regulation, and policy making to assess the current state of cancer policy and discuss ways in which law can influence its development.

Topics discussed

The conference will analyze a variety of subjects at the heart of contemporary cancer care. Speakers will examine the role Washington, D.C. plays in cancer research and treatment through politics, legislation, and lobbying.

They will also outline the ways in which cancer policy is shaped outside the federal government, including through private entities such as cancer centers and insurance companies, and through state governments.

The conference will address special challenges in drug development and pricing as well as how cutting-edge advances in cancer treatment—including precision medicine, immunotherapy, and improvements in the genetic profiling of tumors—interface with existing and proposed government regulations.

Additionally, speakers will consider how disparities and inequalities impact cancer research, regulation, and treatment.

The conference is sponsored by the Solomon Center for Health Law and Policy at Yale Law School, the Yale Cancer Center, the Smilow Cancer Hospital at Yale New Haven, the Yale Health Law and Policy Society (YHeLPS), and Yale Journal of Health Policy, Law, and Ethics. The event is supported by the Oscar M. Ruebhausen Fund at Yale Law School.


Click here to register online.